Acitretin;Acitrétine

Annales de Dermatologie et de Venereologie

Volumn 128, Issue 6-7, 2001, Pages 737-745

  Berbis, Ph ^a  

^a HÔPITAL NORD   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; AROTINOID; CALCIPOTRIOL; CORTICOSTEROID; CYCLINE; ETRETIN; ETRETINATE; METHOTREXATE;

ARTICLE; CHEILITIS; DOSE RESPONSE; DRUG ELIMINATION; DRUG HALF LIFE; DRUG INDUCED DISEASE; DRUG TRANSFORMATION; HAIR LOSS; HUMAN; HYPERLIPIDEMIA; KERATOSIS PALMOPLANTARIS; LICHEN PLANUS; LIGAMENT CALCINOSIS; LIVER TOXICITY; MAJOR CLINICAL STUDY; OSTEOPOROSIS; PHOTOTHERAPY; PUSTULAR PSORIASIS; PUVA; SKIN ABRASION; SKIN DISEASE; TERATOGENESIS; ULTRAVIOLET B RADIATION; XEROSIS;

ACITRETIN; ADULT; CHILD; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; HUMANS; METABOLIC CLEARANCE RATE; SKIN DISEASES;

EID: 0034927697     PISSN: 01519638     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (89)

1. Cis-trans interconversion of acitretin in man
2. Retinoids and psoriasis: Novel issues in retinoid pharmacology and implications for psoriasis treatment
3. Human skin retinoid-binding proteins and therapy with synthetic retinoids: A still unexplained link
4. Therapy with a synthetic retinoid - (Ro 10-1670) etretin-increases the cellular retinoic acid-binding protein in nonlesional psoriatic skin
5. Retinoid binding proteins and human skin
6. Characterization of synthetic retinoids with selectivity for retinoic acid or retinoid X nuclear receptors
7. A rapid and simple test system for the evaluation of the inhibitory activity of retinoids on induced ornithine decarboxylase activity in the hairless rat epidermis
8. Differential effects of retinoids on DNA synthesis in calcium-regulated murine epidermal keratinocyte cultures
9. The effects of retinoid treatment and antiestrogens on the growth of T47D human breast cancer cells
10. Antiproliferative activity of retinoids, interferon alpha and their combination in five human transformed cell lines
11. Retinoid treatment of human psoriatic fibroblasts induces, an increase in cyclic AMP-dependent protein kinase activity
12. Correlation between the induction of leukemic cell differentiation by various retinoids and modulation of protein kinases
13. Retinoids and keratinocyte differenciation in vitro
14. Arotinoid Ro 13-6298 and etretin: Two new retinoids inferior to isotretinoin in sebum suppression and acne treatment
15. Proliferation and glycosaminoglycans secretion in fibroblasts from psoriatic skin: Diffferential responses to retinoids
16. Comparison of the effects of retinoids and glucocorticosteroid on protein and type IV collagen synthesis in HT-1080 (human basement membrane forming fibrosarcoma) cells
17. Inhibition of neutrophil migration by etretinate and its main metabolite
18. Intra-epidermal accumulation of polymorphonuclear leukocytes in persistent palmoplantar pustulosis during treatment with acitretin
19. Synthetic retinoids inhibit the antigen presenting properties of epidermal cells in vitro
20. Trimethylmethoxyphenyl-retinoic acid (Ro 10-1670) and lymphocyte DNA synthesis activity in vitro
21. Stimulatory effects of vitamin A analogs on induction of cell mediated cytotoxicity in vivo
22. Retinoid augmentation of bioactive interleukin-1 production by murine keratinocytes
23. Food increases the bioavailability of acitretin
24. Overview of recent clinical pharmacokinetic studies with acitretin (Ro 10-1670, etretin)
25. Etretinate: Persistent serum levels after long term therapy
26. Residual plasma concentrations of acitretin (Ro l0-1670) and its metabolite (Ro 13- 7652) after chronic administration
27. Pharmacokinetics of acitretin and etretinate
28. On metabolism and pharmacokinetics of an aromatic retinoid
29. Acitretin excretion into human breast milk
30. A potentially new metabolic pathway: Ethyl esterification of acitretin
31. Conversion acitretin to etretinate in psoriatic patients is influenced by ethanol
32. A double-blind comparison of acitretin and etretinate in the treatment of severe psoriasis. Results of a Nordic multicentre study
33. Acitretin (Ro 10-1670, etretin): Overall evaluation of clinical studies
34. Acitretin and etretinate. How and when they should be used
35. Treatment of severe psoriasis with etretin (RO 10-1670)
36. Acitretin improves psoriasis in a dose-dependent fashion
37. Benefit of progressively increasing doses during the initial treatment with acitretin in psoriasis
38. Etretin therapy for severe psoriasis. Evaluation of initial clinical responses
39. Randomized double-blind multicenter study comparing acitretin-PUVA, etretinate-PUVA and placebo-PUVA in the treatment of severe psoriasis
40. Photochemotherapy for severe psoriasis without or in combination with acitretin: A randomized, double-blind comparison study
41. Acitretin in combination with UVB or PUVA
42. Acitretin plus UVB therapy For psoriasis. Comparisons with placebo plus UVB and acitretin alone
43. Combined treatment of psoriasis with acitretin and UVB phototherapy compared with acitretin alone and UVB alone
44. Acitretin combination therapy
45. The effect of addition of calcipotriol ointment (50 micrograms/g) to acitretin therapy in psoriasis
46. Acitretin in the treatment of severe disorders of keratinization. Results of an open study
47. An appraisal of acitretin therapy in children with inherited disorders of keratinization
48. Papillon-Lefevre syndrome. Ultrastructural study and successful treatment with acitretin
49. Papillon-Lefevre syndrome - Successful treatment with a combination of retinoid and concurrent systematic periodontal therapy: Case reports
50. Sjogren-Larsson syndrome: Early diagnosis, dietary management and biochemical studies in two cases
51. Acitretin in the treatment of lamellar ichthyosis
52. Anodontie et dysplasie ectodermique hidrotique, hyporéactive à la chaleur. Effet de l'acitrétine
53. Acitretin in the treatment of erythrokeratodermia variabilis
54. Keratodermia palmo-plantaris papulosa (Buschke-Fischer's disease): Efficacy of acitretin
55. A case of verrucous epidermal naevus successfully treated with acitretin
56. Pityriasis rubra pilaris treated with acitretin and narrow-band ultraviolet B (Re-TL-01)
57. A double-blind comparison of acitretin and etretinate in the treatment of Darier's disease
58. Clinical and ultrastructural effects of acitretin in Darier's disease
59. Treatment of lichen planus with acitretin. A double-blind, placebo-controlled study in 65 patients
60. Acitretin in the treatment of severe lichen sclerosus et atrophicus of the vulva: A double-blind, placebo-controlled study
61. Treatment of cutaneous lupus erythematosus with acitretin and hydroxychloroquine
62. Successful treatment of subcorneal pustular dermatosis (Sneddon-wilkinson disease) by acitretin: Report of a case
63. Folliclite pustuleuse à éosinophiles d'Ofuji: Efficacité de l'acitrétine
64. Acitretin and AIDS-related Reiter's disease
65. Hyperplasie angiolymphoide avec éosinophilie: Rémission sous acitrétine
66. Maladie de Cowden; traitement par acitretine
67. Epidermodysplasia verruciformis: Association with isolated IgM deficiency and response to treatment with acitretin
68. Treatment of palmoplantar lichen nitidus with acitretin
69. Grzybowski's generalized eruptive keratocanthomas: A case report
70. Prevention of skin cancer and reduction of keratotic skin lesions during acitretin therapy in renal transplant recipients: A doubleblind, placebo-controlled study
71. Skin cancer chemoprophylaxis in renal transplant recipients: 5 Years of experience using low-dose acitretin
72. Multiple squamous cell carcinomas in a psoriatic patient following high-dose photochemotherapy and cyclosporin treatment: Responseto long-term acitretin maintenance
73. Treatment of verrucous carcinoma of vulva with acitretin
74. Remission of cutaneous T-cell lymphoma with combined calcitriol and acitretin
75. Incidence and in-vivo relevance of anti-interferon antibodies during treatment of low-grade cutaneous T-cell lymphomas with interferon alpha-2a combined with acitretin or PUVA
76. Prospective randomized multicenter clinical trial on the use of interferon -2a plus acitretin versus interferon -2a plus PUVA in patients with cutaneous T-cell lymphoma stages I and II
77. Teratogenesis and reproductive safety evaluation of the retinoid etretin (RO 10-1670)
78. Severe limb defects and craniofacial anomalies in a fetus conceived during acitretin therapy
79. Acitretin induces an increased adherence of S. aureus to epithelial cells
80. Acitretin in psoriasis: An overview of adverse effects
81. Effects of acitretin on the liver
82. Severe hepatotoxic reaction with progression to cirrhosis after use of a novel retinoid (acitretin)
83. Coma acidocétosique mode de découverte d'une pancréatite aiguë sévère chez un patient non diabétique prenant de I'acitrétine
84. Andrological investigations in patients treated with etretin
85. Osteoporosis is a toxic effect of long term etretinate therapy
86. Skeletal side-effects of 5 years' acitretin treatment
87. Effects of retinoids in bone
88. A prospective study of skeletal changes during short-term acitretin therapy
89. Acitretin (RO10-1670) and oral contraceptives: Interaction study